1	Britain	_	NNP	_	_	3	NMOD	_	_
2	's	_	POS	_	_	1	SUFFIX	_	_
3	Monopolies	_	NNP	_	_	8	SBJ	_	_
4	and	_	CC	_	_	3	COORD	_	_
5	Mergers	_	NNP	_	_	6	NAME	_	_
6	Commission	_	NNP	_	_	4	CONJ	_	_
7	Wednesday	_	NNP	_	_	8	TMP	_	_
8	cleared	_	VBD	_	_	0	ROOT	_	_
9	Rhone-Poulenc	_	NNP	_	_	10	NAME	_	_
10	S.A.	_	NNP	_	_	12	NMOD	_	_
11	's	_	POS	_	_	10	SUFFIX	_	_
12	purchase	_	NN	_	_	8	OBJ	_	_
13	of	_	IN	_	_	12	NMOD	_	_
14	a	_	DT	_	_	17	NMOD	_	_
15	specialty	_	NN	_	_	17	NMOD	_	_
16	bulk-chemical	_	NN	_	_	17	NMOD	_	_
17	unit	_	NN	_	_	13	PMOD	_	_
18	from	_	IN	_	_	12	NMOD	_	_
19	Monsanto	_	NNP	_	_	18	PMOD	_	_
20	Co.	_	NNP	_	_	19	POSTHON	_	_
21	,	_	,	_	_	8	P	_	_
22	saying	_	VBG	_	_	8	ADV	_	_
23	the	_	DT	_	_	24	NMOD	_	_
24	purchase	_	NN	_	_	25	SBJ	_	_
25	was	_	VBD	_	_	22	OBJ	_	_
26	unlikely	_	JJ	_	_	25	PRD	_	_
27	to	_	TO	_	_	26	AMOD	_	_
28	have	_	VB	_	_	27	IM	_	_
29	any	_	DT	_	_	31	NMOD	_	_
30	lasting	_	JJ	_	_	31	NMOD	_	_
31	impact	_	NN	_	_	28	OBJ	_	_
32	on	_	IN	_	_	31	LOC	_	_
33	U.K.	_	NNP	_	_	35	NMOD	_	_
34	industrial	_	JJ	_	_	35	NMOD	_	_
35	consumers	_	NNS	_	_	32	PMOD	_	_
36	.	_	.	_	_	8	P	_	_

1	The	_	DT	_	_	2	NMOD	_	_
2	commission	_	NN	_	_	24	SBJ	_	_
3	,	_	,	_	_	2	P	_	_
4	which	_	WDT	_	_	5	SBJ	_	_
5	was	_	VBD	_	_	2	NMOD	_	_
6	asked	_	VBN	_	_	5	LGS	_	_
7	to	_	TO	_	_	6	OPRD	_	_
8	study	_	VB	_	_	7	IM	_	_
9	the	_	DT	_	_	10	NMOD	_	_
10	deal	_	NN	_	_	8	OBJ	_	_
11	by	_	IN	_	_	6	ADV	_	_
12	the	_	DT	_	_	13	NMOD	_	_
13	Department	_	NNP	_	_	11	PMOD	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	Trade	_	NNP	_	_	14	PMOD	_	_
16	and	_	CC	_	_	15	COORD	_	_
17	Industry	_	NNP	_	_	16	CONJ	_	_
18	after	_	IN	_	_	6	TMP	_	_
19	its	_	PRP$	_	_	20	NMOD	_	_
20	announcement	_	NN	_	_	18	PMOD	_	_
21	in	_	IN	_	_	20	TMP	_	_
22	February	_	NNP	_	_	21	PMOD	_	_
23	,	_	,	_	_	2	P	_	_
24	said	_	VBD	_	_	0	ROOT	_	_
25	the	_	DT	_	_	26	NMOD	_	_
26	diversity	_	NN	_	_	37	SBJ	_	_
27	of	_	IN	_	_	26	NMOD	_	_
28	global	_	JJ	_	_	29	NMOD	_	_
29	supply	_	NN	_	_	27	PMOD	_	_
30	of	_	IN	_	_	29	NMOD	_	_
31	chemicals	_	NNS	_	_	30	PMOD	_	_
32	used	_	VBN	_	_	31	APPO	_	_
33	in	_	IN	_	_	32	LOC	_	_
34	making	_	VBG	_	_	33	PMOD	_	_
35	analgesic	_	JJ	_	_	36	NMOD	_	_
36	drugs	_	NNS	_	_	34	OBJ	_	_
37	was	_	VBD	_	_	24	OBJ	_	_
38	great	_	JJ	_	_	37	PRD	_	_
39	enough	_	RB	_	_	38	AMOD	_	_
40	to	_	TO	_	_	38	AMOD	_	_
41	offset	_	VB	_	_	40	IM	_	_
42	the	_	DT	_	_	46	NMOD	_	_
43	dominant	_	JJ	_	_	46	NMOD	_	_
44	U.K.	_	NNP	_	_	46	NMOD	_	_
45	market	_	NN	_	_	46	NMOD	_	_
46	share	_	NN	_	_	41	OBJ	_	_
47	Rhone-Poulenc	_	NNP	_	_	48	SBJ	_	_
48	would	_	MD	_	_	46	NMOD	_	_
49	gain	_	VB	_	_	48	VC	_	_
50	through	_	IN	_	_	49	ADV	_	_
51	the	_	DT	_	_	52	NMOD	_	_
52	acquisition	_	NN	_	_	50	PMOD	_	_
53	.	_	.	_	_	24	P	_	_

1	The	_	DT	_	_	4	NMOD	_	_
2	French	_	NNP	_	_	4	NMOD	_	_
3	chemical	_	NN	_	_	4	NMOD	_	_
4	giant	_	NN	_	_	5	SBJ	_	_
5	would	_	MD	_	_	0	ROOT	_	_
6	hold	_	VB	_	_	5	VC	_	_
7	an	_	DT	_	_	10	NMOD	_	_
8	80	_	CD	_	_	9	AMOD	_	_
9	%	_	NN	_	_	10	NMOD	_	_
10	share	_	NN	_	_	6	OBJ	_	_
11	of	_	IN	_	_	10	NMOD	_	_
12	the	_	DT	_	_	14	NMOD	_	_
13	U.K.	_	NNP	_	_	14	NMOD	_	_
14	market	_	NN	_	_	11	PMOD	_	_
15	for	_	IN	_	_	14	NMOD	_	_
16	salicylic	_	JJ	_	_	17	NMOD	_	_
17	acid	_	NN	_	_	15	PMOD	_	_
18	,	_	,	_	_	17	P	_	_
19	methyl	_	NN	_	_	20	NMOD	_	_
20	salicylate	_	NN	_	_	17	COORD	_	_
21	and	_	CC	_	_	20	COORD	_	_
22	bulk	_	JJ	_	_	23	NMOD	_	_
23	aspirin	_	NN	_	_	21	CONJ	_	_
24	.	_	.	_	_	5	P	_	_

1	The	_	DT	_	_	2	NMOD	_	_
2	commission	_	NN	_	_	3	SBJ	_	_
3	found	_	VBD	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	OBJ	_	_
5	if	_	IN	_	_	16	ADV	_	_
6	the	_	DT	_	_	8	NMOD	_	_
7	British	_	JJ	_	_	8	NMOD	_	_
8	government	_	NN	_	_	9	SBJ	_	_
9	attempted	_	VBD	_	_	5	SUB	_	_
10	to	_	TO	_	_	9	OPRD	_	_
11	block	_	VB	_	_	10	IM	_	_
12	the	_	DT	_	_	13	NMOD	_	_
13	merger	_	NN	_	_	11	OBJ	_	_
14	,	_	,	_	_	16	P	_	_
15	Rhone-Poulenc	_	NNP	_	_	16	SBJ	_	_
16	would	_	MD	_	_	4	SUB	_	_
17	likely	_	RB	_	_	16	ADV	_	_
18	respond	_	VB	_	_	16	VC	_	_
19	by	_	IN	_	_	18	MNR	_	_
20	closing	_	VBG	_	_	19	PMOD	_	_
21	the	_	DT	_	_	23	NMOD	_	_
22	salicylates	_	NNS	_	_	23	NMOD	_	_
23	plant	_	NN	_	_	20	OBJ	_	_
24	Monsanto	_	NNP	_	_	25	SBJ	_	_
25	operates	_	VBZ	_	_	23	NMOD	_	_
26	in	_	IN	_	_	23	LOC	_	_
27	Wales	_	NNP	_	_	26	PMOD	_	_
28	,	_	,	_	_	18	P	_	_
29	removing	_	VBG	_	_	18	ADV	_	_
30	the	_	DT	_	_	31	NMOD	_	_
31	matter	_	NN	_	_	29	OBJ	_	_
32	from	_	IN	_	_	29	DIR	_	_
33	U.K.	_	NNP	_	_	34	NMOD	_	_
34	jurisdiction	_	NN	_	_	32	PMOD	_	_
35	.	_	.	_	_	3	P	_	_

